Citigroup’s NEVRO CORP. NVRO Stock Holding History

Citigroup’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-400	Closed	-$56K	–	7670
2020 Q3	$56K	Sell	400 -2,100	-84%	-$281K	﹤0.01%	5520
2020 Q2	$299K	Sell	2,500 -5,400	-68%	-$640K	﹤0.01%	4707
2020 Q1	$790K	Buy	7,900 +3,500	+80%	+$421K	﹤0.01%	3416
2019 Q4	$517K	Buy	4,400 +1,500	+52%	+$149K	﹤0.01%	4394
2019 Q3	$249K	Sell	2,900 -1,000	-26%	-$75.7K	﹤0.01%	4968
2019 Q2	$253K	Sell	3,900 -6,300	-62%	-$392K	﹤0.01%	5061
2019 Q1	$638K	Buy	10,200 +8,600	+538%	+$404K	﹤0.01%	3921
2018 Q4	$62K	Buy	+1,600	New	+$71.1K	﹤0.01%	6062

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup's NVRO Position: Q2 2025 in Review

Citigroup sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 26,134 shares — an estimated $153K sold.

Citigroup first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $4.42M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

Citigroup reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
Citigroup sold 26,134 NEVRO CORP. shares in Q2 2025, an estimated $153K.
Citigroup first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
Citigroup's NEVRO CORP. position peaked at $4.42M in Q4 2020.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.